Early	JJ	early JJ PennPOS
growth	NN	growth NN PennPOS
response	NN	response NN PennPOS
transcription	NN	transcription NN PennPOS
factors	NNS	factor NNS PennPOS
:	:	: : NUPOS
key	JJ	key JJ PennPOS
mediators	NNS	mediator NNS PennPOS
of	IN	of pp-f NUPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
novel	JJ	novel JJ PennPOS
targets	NNS	target NNS PennPOS
for	IN	for c-acp NUPOS
anti-fibrotic	JJ	anti-fibrotic JJ PennPOS
therapy	NN	therapy NN PennPOS
.	.	. . NUPOS

Fibrosis	NN	fibrosis NN PennPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
deregulated	VBN	deregulate VBN PennPOS
and	CC	and cc NUPOS
ultimately	RB	ultimate av-j NUPOS
defective	JJ	defective JJ PennPOS
form	NN	form NN PennPOS
of	IN	of pp-f NUPOS
tissue	NN	tissue NN PennPOS
repair	NN	repair NN PennPOS
that	WDT	that WDT PennPOS
underlies	VBZ	underlie VBZ PennPOS
a	DT	a dt NUPOS
large	JJ	large JJ PennPOS
number	NN	number NN PennPOS
of	IN	of pp-f NUPOS
chronic	JJ	chronic JJ PennPOS
human	JJ	human JJ PennPOS
diseases	NNS	disease NNS PennPOS
,	,	, , NUPOS
as	RB	as a-acp NUPOS
well	RB	well av NUPOS
as	IN	as c-acp NUPOS
obesity	NN	obesity NN PennPOS
and	CC	and cc NUPOS
aging	NN	aging NN PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
fibrosis	NN	fibrosis NN PennPOS
involves	VBZ	involve VBZ PennPOS
multiple	JJ	multiple JJ PennPOS
cell	NN	cell NN PennPOS
types	NNS	type NNS PennPOS
and	CC	and cc NUPOS
extracellular	JJ	extracellular JJ PennPOS
signals	NNS	signal NNS PennPOS
,	,	, , NUPOS
of	IN	of pp-f NUPOS
which	WDT	which r-crq NUPOS
transforming	VBG	transform VBG PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
-	:	- : NUPOS
(	(	( ( NUPOS
TGF	NN	tgf NN PennPOS
-	:	- : NUPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
pre-eminent	JJ	pre-eminent j NUPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
prevalence	NN	prevalence NN PennPOS
of	IN	of pp-f NUPOS
fibrosis	NN	fibrosis NN PennPOS
is	VBZ	be vbz NUPOS
rising	VBG	rise VBG PennPOS
worldwide	RB	worldwide RB PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
to	TO	to p-acp NUPOS
date	NN	date NN PennPOS
no	DT	no dx NUPOS
agents	NNS	agent NNS PennPOS
has	VBZ	have vdz NUPOS
shown	VBN	show VBN PennPOS
clinical	JJ	clinical JJ PennPOS
efficacy	NN	efficacy NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
attenuating	NN	attenuating NN PennPOS
or	CC	or cc NUPOS
reversing	VBG	reverse VBG PennPOS
the	DT	the dt NUPOS
process	NN	process NN PennPOS
.	.	. . NUPOS

Recent	JJ	recent JJ PennPOS
studies	NNS	study NNS PennPOS
implicate	VBP	implicate VBP PennPOS
the	DT	the dt NUPOS
immediate-early	JJ	immediate-early JJ PennPOS
response	NN	response NN PennPOS
transcription	NN	transcription NN PennPOS
factor	NN	factor NN PennPOS
Egr-1	NN	Egr-1 NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Egr-1	NN	Egr-1 NN PennPOS
couples	NNS	couple NNS PennPOS
acute	JJ	acute JJ PennPOS
changes	NNS	change NNS PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
cellular	JJ	cellular JJ PennPOS
environment	NN	environment NN PennPOS
to	TO	to p-acp NUPOS
sustained	JJ	sustained JJ PennPOS
alterations	NNS	alteration NNS PennPOS
in	IN	in IN PennPOS
gene	NN	gene NN PennPOS
expression	NN	expression NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
mediates	VBZ	mediate VBZ PennPOS
a	DT	a dt NUPOS
broad	JJ	broad JJ PennPOS
spectrum	NN	spectrum NN PennPOS
of	IN	of pp-f NUPOS
biological	JJ	biological JJ PennPOS
responses	NNS	response NNS PennPOS
to	TO	to p-acp NUPOS
injury	NN	injury NN PennPOS
and	CC	and cc NUPOS
stress	NN	stress NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
contrast	NN	contrast NN PennPOS
to	TO	to p-acp NUPOS
other	JJ	other JJ PennPOS
ligand-activated	JJ	ligand-activated JJ PennPOS
transcription	NN	transcription NN PennPOS
factors	NNS	factor NNS PennPOS
such	JJ	such JJ PennPOS
as	IN	as c-acp NUPOS
NF-kB	NN	NF-kB NN PennPOS
,	,	, , NUPOS
c-jun	NN	c-jun NN PennPOS
and	CC	and cc NUPOS
Smad2/3	NN	Smad2/3 NN PennPOS
that	WDT	that WDT PennPOS
undergo	VBP	undergo VBP PennPOS
post-translational	JJ	post-translational JJ PennPOS
modification	NN	modification NN PennPOS
such	JJ	such JJ PennPOS
as	IN	as c-acp NUPOS
phosphorylation	NN	phosphorylation NN PennPOS
and	CC	and cc NUPOS
nuclear	JJ	nuclear JJ PennPOS
translocation	NN	translocation NN PennPOS
,	,	, , NUPOS
Egr-1	NN	Egr-1 NN PennPOS
activity	NN	activity NN PennPOS
is	VBZ	be vbz NUPOS
regulated	VBN	regulate VBN PennPOS
via	IN	via IN PennPOS
its	PRP$	its po31 NUPOS
biosynthesis	NN	biosynthesis NN PennPOS
.	.	. . NUPOS

Aberrant	JJ	aberrant JJ PennPOS
Egr-1	NN	Egr-1 NN PennPOS
expression	NN	expression NN PennPOS
or	CC	or cc NUPOS
activity	NN	activity NN PennPOS
is	VBZ	be vbz NUPOS
implicated	VBN	implicate VBN PennPOS
in	IN	in IN PennPOS
cancer	NN	cancer NN PennPOS
,	,	, , NUPOS
inflammation	NN	inflammation NN PennPOS
,	,	, , NUPOS
atherosclerosis	NN	atherosclerosis NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
ischemic	JJ	ischemic JJ PennPOS
injury	NN	injury NN PennPOS
and	CC	and cc NUPOS
recent	JJ	recent JJ PennPOS
studies	NNS	study NNS PennPOS
now	RB	now av NUPOS
indicate	VBP	indicate VBP PennPOS
an	DT	a dt NUPOS
important	JJ	important JJ PennPOS
role	NN	role NN PennPOS
for	IN	for c-acp NUPOS
Egr-1	NN	Egr-1 NN PennPOS
in	IN	in IN PennPOS
TGF	NN	tgf NN PennPOS
-	:	- : NUPOS
-	:	- : NUPOS
dependent	JJ	dependent JJ PennPOS
profibrotic	JJ	profibrotic JJ PennPOS
responses	NNS	response NNS PennPOS
.	.	. . NUPOS

Fibrosis	NN	fibrosis NN PennPOS
in	IN	in IN PennPOS
various	JJ	various JJ PennPOS
animal	NN	animal NN PennPOS
models	NNS	model NNS PennPOS
and	CC	and cc NUPOS
human	JJ	human JJ PennPOS
diseases	NNS	disease NNS PennPOS
such	JJ	such JJ PennPOS
as	IN	as c-acp NUPOS
scleroderma	NN	scleroderma NN PennPOS
(	(	( ( NUPOS
SSc	NN	ssc NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
accompanied	VBN	accompany VBN PennPOS
by	IN	by IN PennPOS
aberrant	JJ	aberrant JJ PennPOS
Egr-1	NN	Egr-1 NN PennPOS
expression	NN	expression NN PennPOS
.	.	. . NUPOS

Moreover	RB	moreover av NUPOS
Egr-1	NN	Egr-1 NN PennPOS
appears	VBZ	appear VBZ PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
required	VBN	require VBN PennPOS
for	IN	for c-acp NUPOS
physiologic	JJ	physiologic JJ PennPOS
and	CC	and cc NUPOS
pathological	JJ	pathological JJ PennPOS
connective	JJ	connective JJ PennPOS
tissue	NN	tissue NN PennPOS
remodeling	NN	remodeling NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
Egr-1-null	JJ	egr-1-null JJ PennPOS
mice	NNS	mouse n2 NUPOS
are	VBP	be vbb NUPOS
protected	VBN	protect VBN PennPOS
from	IN	from pp NUPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

As	IN	as c-acp NUPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
profibrotic	JJ	profibrotic JJ PennPOS
mediator	NN	mediator NN PennPOS
,	,	, , NUPOS
Egr-1	NN	Egr-1 NN PennPOS
thus	RB	thus av NUPOS
appears	VBZ	appear VBZ PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
a	DT	a dt NUPOS
promising	JJ	promising JJ PennPOS
potential	JJ	potential JJ PennPOS
target	NN	target NN PennPOS
for	IN	for c-acp NUPOS
the	DT	the dt NUPOS
development	NN	development NN PennPOS
of	IN	of pp-f NUPOS
anti-fibrotic	JJ	anti-fibrotic JJ PennPOS
therapies	NNS	therapy NNS PennPOS
.	.	. . NUPOS

